|
RNF138 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.17279519429303E-11 |
| Normal-vs-Stage3 |
5.99520433297585E-15 |
| Normal-vs-Stage4 |
1.63502544836547E-12 |
| Stage1-vs-Stage2 |
7.818300E-02 |
| Stage1-vs-Stage3 |
9.577800E-02 |
| Stage1-vs-Stage4 |
2.701900E-03 |
| Stage2-vs-Stage3 |
6.438600E-01 |
| Stage2-vs-Stage4 |
3.520200E-01 |
| Stage3-vs-Stage4 |
1.237360E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.12409999992225E-07 |
| Normal-vs-Asian |
4.12610001720992E-09 |
| Caucasian-vs-AfricanAmerican |
8.475600E-01 |
| Caucasian-vs-Asian |
4.285400E-01 |
| AfricanAmerican-vs-Asian |
7.239800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.76996261670138E-15 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
6.920000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.17847961891948E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63935531816151E-12 |
| Normal-vs-Age(81-100Yrs) |
1.935820E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.364900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.116200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.240000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.938000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.688600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.308600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.000300E-02 |
| Classical-VS-Follicular |
3.977500E-03 |
| Classical-VS-Other |
6.392600E-01 |
| Classical-VS-Normal |
1.18180021324577E-10 |
| Tall-VS-Follicular |
8.698600E-01 |
| Tall-VS-Other |
6.853200E-01 |
| Tall-VS-Normal |
1.81110015873287E-10 |
| Follicular-VS-Other |
6.319600E-01 |
| Follicular-VS-Normal |
1.62592161956354E-12 |
| Other-VS-Normal |
1.680570E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
7.79043496379472E-13 |
| N0-vs-N1 |
6.359000E-01 |
|
|
